Accelerate Diagnostics, Inc.
NASDAQ: AXDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jack Phillips
- Employees
- 107
- Headquarters
- Tucson, United States
- IPO year
- 1994
- Market cap
- $859.9K
- Website
- https://acceleratediagnostics.com
Loading AXDX…
Loading profile data…Frequently asked questions about AXDX
What does Accelerate Diagnostics, Inc. (AXDX) do?
Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test...
Where does AXDX trade?
Accelerate Diagnostics, Inc. (AXDX) trades on the NASDAQ Capital Market.
What sector is AXDX in?
Accelerate Diagnostics, Inc. (AXDX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Accelerate Diagnostics, Inc.?
Jack Phillips is the chief executive officer of Accelerate Diagnostics, Inc. (AXDX).
Where is Accelerate Diagnostics, Inc. headquartered?
Accelerate Diagnostics, Inc. is headquartered in United States.
Does AXDX pay a dividend?
Accelerate Diagnostics, Inc. (AXDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AXDX go public?
Accelerate Diagnostics, Inc. (AXDX) completed its initial public offering in 1994.